Cincinnati, OH, United States of America

Andrew John Tofe


Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1976-1980

Loading Chart...
4 patents (USPTO):Explore Patents

Innovative Contributions of Andrew John Tofe in Radiopharmaceuticals

Introduction

Andrew John Tofe, an accomplished inventor based in Cincinnati, OH, has made significant contributions to the field of radiopharmaceuticals. With a total of four patents to his name, Tofe has focused his research on advancing diagnostic techniques in medicine through innovative chemical compositions and methods.

Latest Patents

Among Tofe's recent innovations is a patent for a radiographic scanning agent. This invention involves a composition and method for preparing a technetium-99 m based scintigraphic scanning agent. The agent is synthesized by adding a pertechnetate-99 m solution to an anhydrous salt composition containing either a phosphonic acid or its pharmaceutically acceptable salt, alongside a non-toxic, water-soluble, anhydrous salt of stannous, ferrous or chromous origin, derived from hydrochloric or sulfuric acid.

In addition, Tofe has developed a patent concerning radionuclide carriers. This invention relates to physiologically acceptable particulate radionuclide carriers that incorporate a reducing agent bound to an anionic starch derivative. These carriers are designed for use in preparing organ-specific diagnostic radiopharmaceuticals, reflecting Tofe's commitment to enhancing medical diagnostics.

Career Highlights

Andrew John Tofe is currently associated with The Procter & Gamble Company, where he continues to innovate. His work at this renowned organization not only highlights his technical skills but also his ability to develop valuable solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Tofe has collaborated with notable colleagues such as Marion David Francis and Frederick Anthony Hartman. These partnerships have undoubtedly contributed to the successful development of his patents and have fostered an environment of innovation in the projects he undertakes.

Conclusion

In summary, Andrew John Tofe's dedication to the field of radiopharmaceuticals is evident through his patents and collaborative efforts. His innovative spirit and technical expertise continue to make significant impacts in medical diagnostics, paving the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…